These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 24004441)

  • 1. Involvement of free radicals and oxidative stress in NAFLD/NASH.
    Sumida Y; Niki E; Naito Y; Yoshikawa T
    Free Radic Res; 2013 Nov; 47(11):869-80. PubMed ID: 24004441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty liver induced by free radicals and lipid peroxidation.
    Morita M; Ishida N; Uchiyama K; Yamaguchi K; Itoh Y; Shichiri M; Yoshida Y; Hagihara Y; Naito Y; Yoshikawa T; Niki E
    Free Radic Res; 2012 Jun; 46(6):758-65. PubMed ID: 22468959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities.
    Gambino R; Musso G; Cassader M
    Antioxid Redox Signal; 2011 Sep; 15(5):1325-65. PubMed ID: 20969475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of oxidative stress in non-alcoholic steatohepatitis.
    Koek GH; Liedorp PR; Bast A
    Clin Chim Acta; 2011 Jul; 412(15-16):1297-305. PubMed ID: 21514287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant therapy and drugs interfering with lipid metabolism: could they be effective in NAFLD patients?
    Musso G; Anty R; Petta S
    Curr Pharm Des; 2013; 19(29):5297-313. PubMed ID: 23394094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role.
    Aubert J; Begriche K; Knockaert L; Robin MA; Fromenty B
    Clin Res Hepatol Gastroenterol; 2011 Oct; 35(10):630-7. PubMed ID: 21664213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
    Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
    Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of oxidative stress in non-alcoholic steatohepatitis].
    Mitsuyoshi H; Itoh Y; Okanoue T
    Nihon Rinsho; 2006 Jun; 64(6):1077-82. PubMed ID: 16768112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis.
    Rolo AP; Teodoro JS; Palmeira CM
    Free Radic Biol Med; 2012 Jan; 52(1):59-69. PubMed ID: 22064361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Free oxygen radiacals and kidney diseases--part I].
    Sakac V; Sakac M
    Med Pregl; 2000; 53(9-10):463-74. PubMed ID: 11320727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease.
    Chen G; Ni Y; Nagata N; Xu L; Ota T
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease.
    Smith BW; Adams LA
    Crit Rev Clin Lab Sci; 2011; 48(3):97-113. PubMed ID: 21875310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD).
    Madan K; Bhardwaj P; Thareja S; Gupta SD; Saraya A
    J Clin Gastroenterol; 2006; 40(10):930-5. PubMed ID: 17063114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD).
    Podrini C; Borghesan M; Greco A; Pazienza V; Mazzoccoli G; Vinciguerra M
    Curr Pharm Des; 2013; 19(15):2737-46. PubMed ID: 23092327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic lipid metabolism and non-alcoholic fatty liver disease.
    Tessari P; Coracina A; Cosma A; Tiengo A
    Nutr Metab Cardiovasc Dis; 2009 May; 19(4):291-302. PubMed ID: 19359149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free radicals, antioxidant defense systems, and schizophrenia.
    Wu JQ; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():200-6. PubMed ID: 23470289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dysfunction in nonalcoholic steatohepatitis.
    Serviddio G; Bellanti F; Vendemiale G; Altomare E
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):233-44. PubMed ID: 21476918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic disturbances in non-alcoholic fatty liver disease.
    Byrne CD; Olufadi R; Bruce KD; Cagampang FR; Ahmed MH
    Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.